GGrantIndex
← Leaderboards

John Kurhanewicz

University Of California San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$27,913,734
Attributed
$44,151,645
Total exposure
22
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$44,151,645 · 22

By mechanism

R01$25,894,291 · 9
S10$4,294,353 · 3
U24$3,430,714 · 1
P41$3,343,536 · 4
U01$3,219,768 · 1
R33$2,034,525 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Research focus

Magnetic Resonance ImagingMetabolicImageBiopsyImaging TechniquesMalignant NeoplasmsResponsePyruvateMalignant Neoplasm Of ProstateClinical ResearchBaseMetabolismPre-ClinicalMolecular ImagingSignal TransductionCancer PatientIn VivoClinical TrialsPathologicDesignClinical ManagementProtocols DocumentationTreatment ResponsePathology

Grant awards (81)

Development of Novel Hyperpolarized MR Molecular Imaging Probes Tested in Realistic Pre-Clinical Models and Correlative Science Studies$322,997
P41 · FY2025 · EB · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$626,274
U24 · FY2024 · CA · contact PI
Development of Novel Hyperpolarized MR Molecular Imaging Probes Tested in Realistic Pre-Clinical Models and Correlative Science Studies$322,998
P41 · FY2024 · EB · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$656,819
U24 · FY2023 · CA · contact PI
Development of Novel Hyperpolarized MR Molecular Imaging Probes Tested in Realistic Pre-Clinical Models and Correlative Science Studies$322,997
P41 · FY2023 · EB · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$74,419
U24 · FY2023 · CA · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$656,818
U24 · FY2022 · CA · contact PI
Development of Novel Hyperpolarized MR Molecular Imaging Probes Tested in Realistic Pre-Clinical Models and Correlative Science Studies$340,372
P41 · FY2022 · EB · contact PI
Characterization of PDX SCNC prostate cancer metastatic murine models and development of associated research resources$75,937
U24 · FY2022 · CA · contact PI
High Field MRI For Optimized Translational 1H Multiparametric and Multinuclear Imaging Research$2,000,000
S10 · FY2021 · OD · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$670,222
U24 · FY2021 · CA · contact PI
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring$655,889
R01 · FY2021 · CA · contact PI
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma$633,577
U01 · FY2021 · CA · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$600,901
R01 · FY2021 · CA · contact PI
Preclinical imaging characterization and resource development of PDX SCNC prostate cancer murine models$1
U24 · FY2021 · CA · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$671,381
R01 · FY2020 · CA · contact PI
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI$670,224
U24 · FY2020 · CA · contact PI
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring$655,889
R01 · FY2020 · CA · contact PI
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma$633,577
U01 · FY2020 · CA · contact PI
TR&D2: Development of Novel Hyperpolarized MR Molecular Imaging Probes, Realistic Pre-clinical Models and Correlative Science Methods$316,265
P41 · FY2020 · EB · contact PI
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring$637,566
R01 · FY2019 · CA · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$627,880
R01 · FY2019 · CA · contact PI
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma$626,261
U01 · FY2019 · CA · contact PI
TR&D2: Development of Novel Hyperpolarized MR Molecular Imaging Probes, Realistic Pre-clinical Models and Correlative Science Methods$316,265
P41 · FY2019 · EB · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$678,703
R01 · FY2018 · CA · contact PI
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring$656,096
R01 · FY2018 · CA · contact PI
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma$651,395
U01 · FY2018 · CA · contact PI
TR&D2: Development of Novel Hyperpolarized MR Molecular Imaging Probes, Realistic Pre-clinical Models and Correlative Science Methods$316,265
P41 · FY2018 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,185,440
R01 · FY2017 · EB
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$684,591
R01 · FY2017 · CA · contact PI
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma$674,958
U01 · FY2017 · CA · contact PI
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring$650,042
R01 · FY2017 · CA · contact PI
TR&D2: Development of Novel Hyperpolarized MR Molecular Imaging Probes, Realistic Pre-clinical Models and Correlative Science Methods$316,265
P41 · FY2017 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,185,393
R01 · FY2016 · EB
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$712,949
R01 · FY2016 · EB
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$620,489
R01 · FY2016 · CA · contact PI
TR&D2: Development of Novel Hyperpolarized MR Molecular Imaging Probes, Realistic Pre-clinical Models and Correlative Science Methods$316,356
P41 · FY2016 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,162,611
R01 · FY2015 · EB
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$698,454
R01 · FY2015 · EB
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$619,505
R01 · FY2015 · CA · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,147,784
R01 · FY2014 · EB
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$685,657
R01 · FY2014 · EB
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$583,254
R01 · FY2014 · CA · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$481,279
R01 · FY2014 · CA · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,190,965
R01 · FY2013 · EB
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$704,365
R01 · FY2013 · EB
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$563,723
R01 · FY2013 · CA · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$495,937
R01 · FY2013 · CA · contact PI
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development$153,162
R21 · FY2013 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$613,774
R01 · FY2012 · CA · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$497,610
R01 · FY2012 · CA · contact PI
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development$135,533
R21 · FY2012 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$555,502
R01 · FY2011 · CA · contact PI
Development of Novel Hyperpolarized MR Molecular Imaging Probes and Cell and Tiss$452,756
P41 · FY2011 · EB · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$582,287
R01 · FY2010 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$1,221,350
R01 · FY2009 · EB
MR Based Molecular Imaging of Prostate Cancer$259,677
R01 · FY2009 · CA · contact PI
Hyperpolarized High Field NMR Facility For Metabolic Profiling Of Human Disease$492,373
S10 · FY2008 · RR · contact PI
Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)$387,701
R21 · FY2008 · EB · contact PI
Monitoring Radiation Therapy of Prostate Cancer by MRSI$294,482
R01 · FY2008 · CA · contact PI
MR Based Molecular Imaging of Prostate Cancer$252,330
R01 · FY2008 · CA · contact PI
High Field NMR System for Metabolic Imaging of Human Disease$1,801,980
S10 · FY2007 · RR · contact PI
Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)$384,258
R21 · FY2007 · EB · contact PI
Monitoring Radiation Therapy of Prostate Cancer by MRSI$294,482
R01 · FY2007 · CA · contact PI
MR Based Molecular Imaging of Prostate Cancer$250,049
R01 · FY2007 · CA · contact PI
Hyperpolarized 13c NMR Studies of Prostate Cancer$384,769
R21 · FY2006 · EB · contact PI
Monitoring Radiation Therapy of Prostate Cancer by MRSI$303,277
R01 · FY2006 · CA · contact PI
MR Based Molecular Imaging of Prostate Cancer$255,479
R01 · FY2006 · CA · contact PI
Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)$383,111
R21 · FY2005 · EB
Monitoring Radiation Therapy of Prostate Cancer by MRSI$310,575
R01 · FY2005 · CA
MR Based Molecular Imaging of Prostate Cancer$276,833
R01 · FY2005 · CA
Monitoring Radiation Therapy of Prostate Cancer by MRSI$310,575
R01 · FY2004 · CA
MONITORING RADIATION THERAPY OF PROSTATE CANCER BY MRSI$271,456
R01 · FY2003 · CA
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER$698,839
R33 · FY2002 · CA
MONITORING RADIATION THERAPY OF PROSTATE CANCER BY MRSI$266,599
R01 · FY2002 · CA
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER$664,275
R33 · FY2001 · CA
MONITORING RADIATION THERAPY OF PROSTATE CANCER BY MRSI$261,884
R01 · FY2001 · CA
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER$5,667
R33 · FY2001 · CA
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER$665,744
R33 · FY2000 · CA
MONITORING RADIATION THERAPY OF PROSTATE CANCER BY MRSI$259,327
R01 · FY2000 · CA
METABOLIC STUDIES OF RESPONSE TO PROSTATE CANCER THERAPY$105,924
R29 · FY2000 · CA